SingJoint® CE 2460 Sodium Hyaluronate Gel – Advanced Joint Care for Osteoarthritis Relief
SingJoint® is a CE-certified intra-articular injection designed for the treatment of osteoarthritis-related knee pain and stiffness. Formulated with high-purity, non-animal origin sodium hyaluronate (HA) at 10–12 mg/mL, it restores joint lubrication, relieves pain, and improves mobility by supplementing the body’s natural synovial fluid.
Manufactured through high-tech bioengineering from streptococcal fermentation, SingJoint® offers exceptional safety with no risk of viral contamination or animal-derived allergens. Its macromolecular structure and high viscoelasticity stimulate endogenous HA production, reduce inflammation, and help slow cartilage degradation.
Key Advantages:
High-Quality HA: Biosynthetically derived, sterile, pyrogen-free, and non-animal origin.
Effective Pain Relief: Improves joint function, reduces stiffness, and relieves pain for OA patients.
Strong Biocompatibility: No known genetic toxicity, skin irritation, or allergic responses.
Trusted Clinical Use: Administered as a weekly injection for 3–4 sessions per treatment course.
Ready-to-Use Design: Pre-filled syringe with Luer-lock fitting ensures convenient and sterile application.
Multiple Formulations: Available in 10 mg/mL and 12 mg/mL concentrations, in 1.0 to 2.5 mL sizes.
Ideal for orthopedic clinics and hospitals, SingJoint® is a reliable, clinically-backed solution to restore joint health and enhance patient comfort—one injection at a time.